Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Study to Evaluate the Effects of Patiromer in Heart Failure Patients
NCT00868439 is registered in ClinicalTrials.gov with Relypsa, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Study to Evaluate the Effects of Patiromer in Heart Failure Patients
- Lead sponsor
- Relypsa, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- December 31, 2009
- Enrollment
- 120 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.